Akero Therapeutics, Inc.
NASDAQ:AKRO
54.28 (USD) • At close June 6, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0.284 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0 | 0 | 0 | 0.001 | 0.001 | 0.002 | 0.005 | 0.069 | 0.068 | 0.065 | 0.066 | 0.065 | 0.064 | 0.063 | 0.06 | 0.06 | 0.061 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 0 | 0 | 0 | -0.001 | -0.001 | 0.282 | -0.005 | -0.069 | -0.068 | -0.065 | -0.066 | -0.065 | -0.064 | -0.063 | -0.06 | -0.06 | -0.061 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0.993 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 69.567 | 69.293 | 72.232 | 55.322 | 50.65 | 53.392 | 38.634 | 27.985 | 21.787 | 18.32 | 25.087 | 21.363 | 20.514 | 27.711 | 19.47 | 23.976 | 10.602 | 25.709 | 17.379 | 13.037 | 8.791 | 13.138 | 13.885 | 5.96 | 4.063 | 1.983 | 1.253 | 8.42 | 0.226 | 0.68 |
| General & Administrative Expenses
| 11.315 | 8.732 | 9.471 | 10.419 | 9.304 | 8.481 | 7.981 | 7.644 | 6.966 | 7.1 | 11.004 | 6.231 | 5.537 | 4.728 | 4.883 | 4.99 | 4.526 | 4.074 | 4.159 | 3.417 | 3.588 | 3.083 | 2.424 | 1.649 | 1.449 | 0.985 | 0.474 | 0.242 | 0.195 | 0.28 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | -0.001 | -0.001 | -0.002 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 11.315 | 8.732 | 9.471 | 10.418 | 9.303 | 8.479 | 7.981 | 7.644 | 6.966 | 7.1 | 11.004 | 6.231 | 5.537 | 4.728 | 4.883 | 4.99 | 4.526 | 4.074 | 4.159 | 3.417 | 3.588 | 3.083 | 2.424 | 1.649 | 1.449 | 0.985 | 0.474 | 0.242 | 0.195 | 0.28 |
| Other Expenses
| 0 | 0 | 0 | -10.418 | 0 | -16.626 | 7.844 | 5.403 | 3.379 | 2.723 | 0.873 | 0.244 | 0 | 0.015 | 0.023 | 0.033 | 0.038 | 0.072 | 0.135 | 0.247 | 0.493 | 0.61 | 0.755 | 0.381 | 0.15 | -58.504 | -9.421 | -0.011 | 0 | 0 |
| Operating Expenses
| 80.882 | 78.025 | 81.703 | 65.74 | 59.953 | 61.871 | 46.615 | 35.629 | 28.753 | 25.42 | 36.091 | 27.594 | 26.051 | 32.439 | 24.353 | 28.966 | 15.128 | 29.783 | 21.538 | 16.454 | 12.379 | 16.221 | 16.309 | 7.609 | 5.512 | 2.968 | 1.727 | 8.662 | 0.421 | 0.96 |
| Operating Income
| -80.882 | -78.025 | -81.703 | -65.741 | -59.954 | -61.873 | -46.615 | -35.629 | -28.753 | -25.42 | -36.091 | -27.594 | -26.051 | -32.439 | -24.353 | -28.966 | -15.128 | -29.783 | -21.538 | -16.454 | -12.379 | -16.221 | -16.309 | -7.609 | -5.512 | -2.968 | -1.727 | -8.662 | -0.421 | -0.96 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | -217.863 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 10.157 | 8.001 | 8.998 | 9.754 | 6.61 | 6.687 | 6.956 | 4.546 | 2.922 | 2.361 | 0.549 | 0.191 | 0.022 | 0.015 | 0.023 | 0.033 | 0.038 | 0.072 | 0.135 | 0.247 | 0.493 | 0.61 | 0.755 | 0.381 | 0.15 | -58.504 | -9.421 | -0.011 | 0 | 0 |
| Income Before Tax
| -70.725 | -70.024 | -72.705 | -55.987 | -53.344 | -55.186 | -39.659 | -31.083 | -25.831 | -23.059 | -35.542 | -27.403 | -26.029 | -32.424 | -24.33 | -28.933 | -15.09 | -29.711 | -21.403 | -16.207 | -11.886 | -15.611 | -15.554 | -7.228 | -5.362 | -61.472 | -11.148 | -8.673 | -0.421 | -0.96 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | -194.317 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 0 | 0 | 0 | -0.042 | -12.527 | 8.732 | 6.26 | -2.465 | -2.574 | -0.549 | 0.297 | -0.022 | -0.011 | -0.051 | -0.05 | -0.05 | -0.011 | -0.006 | -1.323 | -1.237 | -0.046 | -16.309 | -7.609 | -5.362 | -2.968 | 0 | -8.662 | -0.421 | 0 |
| Net Income
| -70.725 | -70.024 | -72.705 | -55.987 | -53.344 | -55.186 | -39.659 | -31.083 | -23.366 | -20.485 | -34.993 | -27.403 | -26.007 | -32.424 | -24.33 | -28.933 | -15.09 | -29.711 | -21.403 | -16.207 | -11.886 | -15.611 | -15.554 | -7.228 | -5.362 | -61.472 | -11.148 | -8.673 | -0.421 | -1.026 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | -194.317 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.9 | -0.99 | -1.05 | -0.81 | -0.9 | -0.99 | -0.71 | -0.6 | -0.5 | -0.44 | -0.91 | -0.77 | -0.74 | -0.93 | -0.7 | -0.83 | -0.43 | -0.86 | -0.63 | -0.57 | -0.42 | -0.55 | -0.56 | -2.21 | -0.2 | -2.9 | -0.53 | -0.41 | -0.02 | -4.54 |
| EPS Diluted
| -0.9 | -0.99 | -1.05 | -0.81 | -0.9 | -0.99 | -0.71 | -0.6 | -0.5 | -0.44 | -0.91 | -0.77 | -0.74 | -0.93 | -0.7 | -0.83 | -0.43 | -0.86 | -0.63 | -0.57 | -0.42 | -0.55 | -0.56 | -2.21 | -0.2 | -2.9 | -0.53 | -0.41 | -0.02 | -4.53 |
| EBITDA
| -80.882 | -68.809 | -71.458 | -54.755 | -52.352 | -54.287 | -38.766 | -30.157 | -25.306 | -22.632 | -35.152 | -27.285 | -25.965 | -32.428 | -24.27 | -28.873 | -15.117 | -29.772 | -21.538 | -16.454 | -12.379 | -16.221 | -16.309 | -7.609 | 0.15 | -2.968 | -11.148 | -0.081 | -0.421 | -0.066 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | -191.151 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |